Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Primary Care

 

Apollo sells stakes

German insurer, Munich Re, has almost doubled its stake in an Indian JV with the hospital group Apollo, Apollo Munich Health Insurance. Munich purchased another 23.3% of the equity for 163.5 Crore INR (US$24m), taking its stake to 48.7%. Apollo is also selling a 30% stake in its outpatient business, Apollo Health and Lifestyle (AHLL), for around 500 crore INR (US$73m). KKR, Carlyle and Apax are all said to be in the running.

Ribera and Centene are still buying

Spanish operator Ribera Salud wants to expand its 35% stake to full ownership in the controversial Alzira-style hospital concession in Dénia, in the Valencian autonomy of Spain. German insurer DKV own the remaining 65% and would almost certainly be willing to sell cheap. The concession is unprofitable, the Valencian government is set to terminate it and, according to Spanish press reports, even refuses to meet the CEO of Ribera. The puzzle is why Ribera and its backer American giant Centene would want to pump more money into what looks like a doomed model.

Medstar invests $100m in UAE

Emirates-based day surgery group Medstar is investing $100m to open new facilities in Dubai, Sharjah, Ras al-Khaimah and Al-Ain. It opened its first clinic in Dubai in late 2015, and is working with insurers to cut costs by 25-30% compared to hospital groups, founding doctor Sajid Burud says. Day surgery clinics are set to proliferate, as the UAE implements Mandatory Health Insurance (MHI).

Revolutionary health wallet app targets low income patients

M-Tiba, a ‘mobile health wallet’ aimed at low-income patients to spend on healthcare, is launching in Kenya. Created by PharmAccess Foundation and CarePay, it works in partnership with Safaricom, the largest mobile operator in the country with 25.1m users and 1,800 public and private healthcare services providers. We look at its possible impacts.

Falck gambles on Africa

Danish healthcare provider Falck is starting a primary care operation in Sub-Saharan Africa. The investment is backed by the World Bank's investment arm, IFC, and the Danish Investment Fund for Developing Countries, IFU, The total investment is $100m with the first clinic expected to open in the first half of 2016.

Meinian turns up the heat on iKang

Chinese healthcare outpatient clinic group Meinian Onehealth Healthcare has increased its offer to rival iKang, which aims to delist from NASDAQ, to US$23.50 per American Depositary Share (ADS). This comes two weeks after iKang adopted a poison pill in response to Meinian's original counter-bid to take the group private, giving the right to its shareholders to buy more shares if Meinian manages to acquire a stake.

Jeremy Hunt plans bigger role for pharmacies

Jeremy Hunt, Secretary of State for Health in the UK, plans to give pharmacies a much bigger role in care, say sources who say he plans to circumvent the Pharmaceutical Services Negotiating Committee, powerful body in which the large chains, such as Boots, are strongly represented.

Poland’s largest pharma distributor pushes into outpatient sector

Warsaw-listed Neuca Group claims to be Poland’s first wholesale pharmaceutical distributor. It has created a large network of subsidiaries looking at the healthcare market. One of them, Neuca Med, aims to create one of the largest networks of clinics in the country and just acquired Medic Klinika, a chain of outpatient centres.

Medlife fails to find a buyer

Value4Capital is struggling to sell its 40% stake in Medlife, Romania’s largest healthcare operator, say reliable sources. We look at why.

Pihlajalinna plans war chest

Having IPOed as recently as June 2015, Finnish healthcare group Pihlajalinna is to ask shareholders for a mandate to issue an extra €40m in shares. The shares have soared 70% above the IPO price to over €17. A €40m issue would leave the company with €70m of net cash. What might the company buy and what does the move tell us about the Finnish market?

Find Us